---
title: "Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform | KZIA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282839865.md"
description: "Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform | KZIA Stock News"
datetime: "2026-04-15T04:00:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282839865.md)
  - [en](https://longbridge.com/en/news/282839865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282839865.md)
---

# Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform | KZIA Stock News

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform | KZIA Stock News

### Related Stocks

- [KZIA.US](https://longbridge.com/en/quote/KZIA.US.md)
- [KZA.AU](https://longbridge.com/en/quote/KZA.AU.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer | KZIA Stock News](https://longbridge.com/en/news/287627288.md)
- [Tempus Announces FDA Approval For Tumor Only XT CDx](https://longbridge.com/en/news/288070238.md)
- [Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer](https://longbridge.com/en/news/288162016.md)
- [Sobi to present new data on pegcetacoplan at ERA 2026](https://longbridge.com/en/news/288238139.md)
- [Bristol Myers Squibb Says Phase 3 Successor-2 Trial Shows MeziKd Achieves 18-Month Median PFS](https://longbridge.com/en/news/288067720.md)